Condition
Respiratory Viral Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Respiratory Viral Infection clinical trials that are recruiting, at sites in 7 countries (most in United States (3), France (1), China (1)). By phase: Phase 3 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 7Countries
Newest Respiratory Viral Infection clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AP1189 added to standard care for adults hospitalized with respiratory viral infections | Phase 2 | Mostar, Herzegovina-Neretva Canton and 10 other locations | Recruiting | Jun 8, 2026 |
| Type I interferon response in the nose during respiratory viral infections in older adults | — | Lyon | Recruiting | May 22, 2026 |
| JKN2301 dry suspension versus oseltamivir for treating flu in children 2 to under 12. | Phase 3 | Guangzhou, Guangdong | Recruiting | Jan 21, 2026 |
| A program to empower community health workers to combat vaccine misinformation | — | Chicago, Illinois and 3 other locations | Recruiting | May 16, 2024 |
| Understanding how respiratory infections affect lung inflammation from ozone exposure | Phase 1 | Durham, North Carolina | Recruiting | Mar 17, 2023 |
| Understanding respiratory viral infections in pediatric transplant recipients | — | Birmingham, Alabama and 26 other locations | Recruiting | Sep 22, 2022 |
All recruiting trials (6)
-
AP1189 added to standard care for adults hospitalized with respiratory viral infections
This study tests whether taking AP1189 once daily for 14 days, in addition to standard care, helps hospitalized patients with pneumonia-like breathing problems caused by a respiratory virus.
-
Type I interferon response in the nose during respiratory viral infections in older adults
This study tests whether a nasal Type I interferon score can help identify respiratory viral infections in older adults already diagnosed by standard tests in a geriatric ward.
-
JKN2301 dry suspension versus oseltamivir for treating flu in children 2 to under 12.
This study tests whether JKN2301 dry suspension is safe and helps treat uncomplicated influenza in children aged 2 to 11, compared with oseltamivir or placebo.
-
A program to empower community health workers to combat vaccine misinformation
This study is testing a program that helps community health workers from Hispanic backgrounds use their personal stories to fight vaccine misinformation and boost vaccination rates in their communities.
-
Understanding how respiratory infections affect lung inflammation from ozone exposure
This study is testing how past respiratory infections affect lung inflammation in people aged 18-55 when they are exposed to ozone.
-
Understanding respiratory viral infections in pediatric transplant recipients
This study is trying to see if measuring respiratory viruses before a transplant can help predict which kids might get respiratory infections afterward.
Related topics
Quick answers
How many Respiratory Viral Infection clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (3 trials), France (1 trial), China (1 trial), Bosnia and Herzegovina (1 trial), Montenegro (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.